Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants Recruiting

2024-513069-37-00 Healthy 1 2026-01-30
A Study to Learn About the Investigational Medicine Called Mevrometostat (PF-06821497) in Men With Metastatic Castration-Sensitive Prostate … Recruiting

2024-519369-24-00 METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER 5 2026-01-29
A study to investigate the effect of capivasertib on the pharmacokinetics of oral dextromethorphan (CYP2D6) in healthy participants Recruiting

2025-523995-21-00 Healthy participants 3 2026-01-27
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants. Recruiting

2025-523587-20-00 Not applicable for phase I study 3 2026-01-05
Comparative Bioavailability of Levonorgestrel 52 mg Intrauterine System versus Mirena® in Healthy Pre-Menopausal, Non-Pregnant Female Partic… Recruiting

2025-523736-39-00 No medical condition. 2 2025-12-29
A Phase I double blinded, single-center, randomized, crossover study comparing the PK, PD, safety and tolerability of a single IV dose (1µg/… Recruiting

2024-518285-27-00 Not applicable (submitted trial is a bioequivalence stu 2 2025-12-01
Urinary proteomics to guide early intervention to prevent complications in type 2 diabetes – a feasibility study Recruiting

2024-518682-95-00 Type 2 Diabetes 6 2025-10-20
A Phase 3, randomized, parallel-group, double-blind, multicenter study investigating the safety and efficacy of NT 201 compared with placebo… Recruiting

2025-520499-24-00 Moderate to Severe Platysma Prominence 5 2025-10-01
CReep and maintenance flUid Salt ADministration rEduction in cRitically ill adultS - (CRUSADERS) Recruiting

2025-520744-14-00 Critically ill patients 6 2025-10-01
A Study of NTX-1088 as Monotherapy and Combined with Pembrolizumab Recruiting

2024-520077-12-00 Patients with Advanced Solid Malignancies 1 2025-09-15
Ergogenic effects of pseudoephedrine on edurance performance in relation to the determination of threshold values in urine and capillary and… Recruiting

2024-513810-36-00 Healthy volunteers 6 2025-08-27
SGL-TX-GFR SGLT2i safety and efficacy on kidney allograft function in non-diabetic kidney transplant recipients: A randomized, double-blind,… Recruiting

2024-518773-33-00 Kidney transplant recipients 6 2025-08-12
Tacrolimus monotherapy in elderly kidney transplant recipients Recruiting

2024-517709-10-00 kidney transplantation 6 2025-08-04
Safety and Efficacy of Intravenous Thrombolysis in Patients with Ischemic Stroke on Treatment with Direct Oral Anticoagulants: DO-IT – The D… Recruiting

2024-515561-34-01 Acute ischemic stroke with recent ingestion of direct o 6 2025-08-04
A Phase I, randomized, consecutive dose, double blind, parallel study comparing the PK, PD, immunogenicity, safety and tolerability of LB-07… Recruiting

2024-518286-95-00 Not applicable (submitted trial is a bioequivalence stu 2 2025-07-02
Therapeutic effect of Hydroxychloroquine on IgA Nephropathy course - QUIgAN Study Recruiting

2024-512653-25-00 IgA nephropathy 5 2025-06-26
ODORAT : Optimal dose of anti-lymphocyte globulin in kidney transplant recipients with low immunological risk Recruiting

2024-514792-17-00 renal transplant 4 2025-06-24
CKD-bioMatch: A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney disease Recruiting

2023-507449-27-01 Chronic kidney disease 6 2025-06-20
IFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as p… Recruiting

2024-517325-43-00 multiple myeloma 4 2025-06-19
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_3). Proof of concept Recruiting

2024-519780-18-00 Healthy volunteers 3 2025-06-11
FORE-PAIN trial Recruiting

2022-500176-63-00 Acute traumatic pain 5 2025-05-20
FusionVAC22_02: DNAJB1-PRKACA fusion transcript-based peptide vaccine for fibrolamellar hepatocellular carcinoma patients and other tumor en… Recruiting

2024-519387-41-00 tumor entities carrying the oncogenic driver fusion 1 2025-05-07
Itraconazole (ITRA) with standard radiotherapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma multiforme (GBM) IT… Recruiting

2024-519239-40-01 Glioblastom 3 2025-04-07
Randomized, double-blind, placebo-controlled Phase I study in healthy individuals on autotaxin-inhibition with MJK2134025 in single-ascendin… Recruiting

2024-513116-10-00 Stroke 1 2025-03-31